← All case studies
Deep-tech / scientific software

LabCanvas Private Limited

A DPIIT-recognised deep-tech founder needed non-dilutive seed capital to move from a validated prototype toward a market-ready product — and had to present a Startup India Seed Fund (SISFS) application that would clear an incubator selection committee.

SECTOR
Deep-tech / scientific software
The challenge

A clear-eyed look at where they stood.

LabCanvas Private Limited is a DPIIT-recognised deep-tech startup building scientific software. At seed stage, the founder had already validated the prototype but still needed capital to carry it to a market-ready product, and wanted that capital on non-dilutive terms rather than giving up equity this early. The Startup India Seed Fund Scheme (SISFS) was the fit: it funds exactly this validation-to-market gap, disbursed through a DPIIT-approved incubator rather than directly by the government.

SISFS gives a startup one route, not a menu to combine: a grant of up to ₹20 lakh, or a convertible-debenture / debt-linked instrument of up to ₹50 lakh, never both. Picking the debt-linked route unlocks a materially higher ceiling, but it also means the incubator’s selection committee holds the application to a higher bar, because they’re assessing repayment and scaling potential, not just early validation. The application has to make that case convincingly, in front of a committee panel that is rarely made up of specialists in the founder’s own technical domain.

That combination is where most SISFS applications lose ground: founders can explain their science to other scientists, but a seed-fund committee needs the same substance translated into a fundable narrative, backed by a utilisation plan the scheme will actually permit and a fund-release structure the committee can sanction with confidence.

What we did

CapEasy structured the SISFS application end to end, starting with confirming DPIIT eligibility and building the case for the convertible-debenture route over the grant, given LabCanvas’s need for the larger ceiling to carry a validated prototype to a market-ready product.

We built the utilisation plan strictly against scheme-permitted heads, so the committee reviewing it would find every rupee accounted for against an allowed category rather than a generic budget line.

Alongside that, we built the milestone-linked tranche plan and the financial model the committee actually assesses when it sanctions a debt-linked instrument, since that model is what carries the scaling and repayment story the debenture route requires.

The last piece was narrative: taking genuinely technical, deep-tech work and shaping how it read to a selection committee that reviews applications across sectors, not one built around LabCanvas’s own domain. The goal was a proposal a non-specialist panel could assess on its merits without needing a briefing first.

The outcome

The application was approved for a ₹40 lakh SISFS convertible debenture through the NSUT incubator. A Seed Fund approval is the incubator committee’s sanction; actual disbursement follows the scheme’s own due-diligence and compliance milestones and is not guaranteed by that sanction alone.

What made it work

The instrument choice was deliberate, not default: matching the funding ask to the debt-linked route’s higher ceiling meant the case had to justify that scale from the outset, rather than retrofitting a scaling story onto a grant-sized application.

Keeping the utilisation plan inside scheme-permitted heads and structuring the tranches around milestones gave the incubator committee a sanction it could grant with a clear release mechanism already built in, rather than an open-ended ask it would need to renegotiate later.

Stat highlights
₹40 Lakh
SISFS convertible debenture — approved
NSUT
Incubator

This describes work CapEasy delivered in a real engagement. Outcomes vary by company, sector and stage; nothing here is a promise of a similar result. CapEasy is a private consultancy and is not affiliated with any government authority.

← Back to all case studies

Book a free consultation.

An honest assessment of where you are and what comes next — no cost, no pressure, no inflated promises.